Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
54.80
+1.80 (3.40%)
Oct 27, 2025, 3:52 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 41.84M NOK in the quarter ending September 30, 2025, with 27.94% growth. This brings the company's revenue in the last twelve months to 172.52M, up 17.42% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.

Revenue (ttm)
172.52M
Revenue Growth
+17.42%
P/S Ratio
4.90
Revenue / Employee
2.74M
Employees
63
Market Cap
845.14M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024152.07M16.92M12.52%
Dec 31, 2023135.15M23.23M20.76%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Medistim ASA662.18M
Nordhealth AS578.17M
Navamedic ASA523.56M
Photocure ASA522.86M
Omda AS458.96M
Vistin Pharma ASA452.25M
ContextVision AB122.97M
ArcticZymes Technologies ASA104.33M
Revenue Rankings